TY - JOUR
T1 - Forecasting stroke and stroke-driven dementia in a rapidly ageing population
T2 - a model-based analysis of alternative projection scenarios for Ireland
AU - Sexton, Eithne
AU - O'Flaherty, Martin
AU - Hickey, Anne
AU - Williams, David J.
AU - Horgan, Frances
AU - MacEy, Chris
AU - Timmons, Suzanne
AU - Collins, Rónán
AU - Bennett, Kathleen E.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025/2/5
Y1 - 2025/2/5
N2 - Objective Understanding future population needs is key for informing stroke service planning. This study aims to evaluate scenarios for future trends in stroke age-specific incidence and case fatality, and estimate their impact on projected stroke and poststroke dementia prevalence in Ireland. Design This is an epidemiological modelling study based on a probabilistic Markov model. We extrapolated trends in age-specific stroke incidence and case fatality from 1990 to 2019 and applied these to 2016 to 2046. We defined trend scenarios based on stability and low and high decline, broadly based on the lower and upper bounds of evidence for trends to date. We also examined nonlinear trends involving decelerating decline over time and varying trends by age. Setting/participants The study is conducted on the Irish population aged 40-89 years in the period 2022-2046. We used multiple data sources, including systematic review and observational evidence. Interventions Not applicable. Primary and secondary outcome measures We projected the incidence and prevalence of stroke (International Classification of Disease (ICD) codes I60-I61, I63-I64), poststroke dementia (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria) and poststroke disability (modified Rankin Scale 3-5). Results The stable scenario indicated a projected 85 834 stroke survivors in 2046 (95% uncertainty interval (UI)=82 366-89 655), an increase of 45.7% from 2022. Assuming a high incidence decline and low case-fatality decline indicated a 5.4% increase in prevalence. Intermediate scenarios based on lower rates of decline, or decline rates slowing over time, implied an increase between 25.8% and 40.3%. Results did not differ substantially when we varied trends by age. In the stable scenario, we projected 16 978 poststroke dementia prevalent cases in 2046 (95% UI 14 958-19 157), an increase of 58.9% from 2022. In the high decline scenario, the increase would be 24.5%, with intermediate scenarios implying an increase between 41.3% and 56.3%. Conclusions Future stroke healthcare needs will vary substantially depending on epidemiological trends. There is an urgent need to both invest in prevention strategies and plan for likely increases in future stroke care needs.
AB - Objective Understanding future population needs is key for informing stroke service planning. This study aims to evaluate scenarios for future trends in stroke age-specific incidence and case fatality, and estimate their impact on projected stroke and poststroke dementia prevalence in Ireland. Design This is an epidemiological modelling study based on a probabilistic Markov model. We extrapolated trends in age-specific stroke incidence and case fatality from 1990 to 2019 and applied these to 2016 to 2046. We defined trend scenarios based on stability and low and high decline, broadly based on the lower and upper bounds of evidence for trends to date. We also examined nonlinear trends involving decelerating decline over time and varying trends by age. Setting/participants The study is conducted on the Irish population aged 40-89 years in the period 2022-2046. We used multiple data sources, including systematic review and observational evidence. Interventions Not applicable. Primary and secondary outcome measures We projected the incidence and prevalence of stroke (International Classification of Disease (ICD) codes I60-I61, I63-I64), poststroke dementia (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria) and poststroke disability (modified Rankin Scale 3-5). Results The stable scenario indicated a projected 85 834 stroke survivors in 2046 (95% uncertainty interval (UI)=82 366-89 655), an increase of 45.7% from 2022. Assuming a high incidence decline and low case-fatality decline indicated a 5.4% increase in prevalence. Intermediate scenarios based on lower rates of decline, or decline rates slowing over time, implied an increase between 25.8% and 40.3%. Results did not differ substantially when we varied trends by age. In the stable scenario, we projected 16 978 poststroke dementia prevalent cases in 2046 (95% UI 14 958-19 157), an increase of 58.9% from 2022. In the high decline scenario, the increase would be 24.5%, with intermediate scenarios implying an increase between 41.3% and 56.3%. Conclusions Future stroke healthcare needs will vary substantially depending on epidemiological trends. There is an urgent need to both invest in prevention strategies and plan for likely increases in future stroke care needs.
KW - Dementia
KW - Ireland
KW - Prevalence
KW - Stroke
UR - https://www.scopus.com/pages/publications/85217124108
U2 - 10.1136/bmjopen-2024-091557
DO - 10.1136/bmjopen-2024-091557
M3 - Article
C2 - 39909517
AN - SCOPUS:85217124108
SN - 2044-6055
VL - 15
JO - BMJ Open
JF - BMJ Open
IS - 2
M1 - e091557
ER -